22249-Lymphomas-NA-129

Lymphomas

First-in-Human Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of the BTK Degrader, ABBV-101, in Participants with B-cell Malignancies (M23-647)

  • Details

ClinicalTrials.gov ID: NCT05753501
Diagnosis Type: NA
USOR Number:

  • Address

1800 N Williams St, Suite 200
Denver, CO 80218
P: (303) 388-4876

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.